| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Asthma | 29 | 2014 | 6167 | 1.430 |
Why?
|
| Urban Health Services | 3 | 2007 | 177 | 0.710 |
Why?
|
| Urban Health | 4 | 2011 | 533 | 0.600 |
Why?
|
| Renin | 10 | 2014 | 636 | 0.550 |
Why?
|
| Anti-Asthmatic Agents | 3 | 2006 | 565 | 0.530 |
Why?
|
| Preventive Medicine | 1 | 2017 | 250 | 0.520 |
Why?
|
| Insurance Claim Review | 2 | 2017 | 737 | 0.450 |
Why?
|
| Investments | 1 | 2013 | 148 | 0.390 |
Why?
|
| Bovine Virus Diarrhea-Mucosal Disease | 3 | 2023 | 4 | 0.390 |
Why?
|
| Herpesvirus 1, Bovine | 3 | 2023 | 6 | 0.340 |
Why?
|
| Diarrhea Viruses, Bovine Viral | 2 | 2023 | 6 | 0.330 |
Why?
|
| Vermont | 3 | 2017 | 83 | 0.310 |
Why?
|
| Los Angeles | 9 | 2014 | 243 | 0.290 |
Why?
|
| Urban Population | 5 | 2011 | 2021 | 0.280 |
Why?
|
| Attitude to Health | 4 | 2014 | 2028 | 0.270 |
Why?
|
| Cattle Diseases | 2 | 2023 | 52 | 0.270 |
Why?
|
| Disease Management | 3 | 2007 | 2508 | 0.270 |
Why?
|
| Viral Vaccines | 3 | 2023 | 598 | 0.250 |
Why?
|
| Patient-Centered Care | 1 | 2015 | 1416 | 0.250 |
Why?
|
| Diarrhea Virus 1, Bovine Viral | 2 | 2023 | 2 | 0.240 |
Why?
|
| Health Surveys | 4 | 2009 | 4061 | 0.230 |
Why?
|
| Absenteeism | 1 | 2005 | 250 | 0.230 |
Why?
|
| Health Care Costs | 2 | 2015 | 3257 | 0.220 |
Why?
|
| Mannheimia | 1 | 2023 | 1 | 0.220 |
Why?
|
| Leukopenia | 1 | 2023 | 212 | 0.210 |
Why?
|
| Patients | 1 | 2009 | 906 | 0.210 |
Why?
|
| Managed Care Programs | 1 | 2006 | 939 | 0.190 |
Why?
|
| Insurance Benefits | 1 | 2003 | 191 | 0.190 |
Why?
|
| Tobacco Smoke Pollution | 4 | 2014 | 810 | 0.180 |
Why?
|
| School Health Services | 1 | 2004 | 382 | 0.180 |
Why?
|
| Insurance, Pharmaceutical Services | 1 | 2003 | 345 | 0.180 |
Why?
|
| Patient Compliance | 3 | 2009 | 2689 | 0.180 |
Why?
|
| Child, Preschool | 16 | 2015 | 42034 | 0.180 |
Why?
|
| Quality of Health Care | 1 | 2015 | 4361 | 0.180 |
Why?
|
| Data Collection | 2 | 2006 | 3317 | 0.170 |
Why?
|
| Program Development | 1 | 2005 | 1297 | 0.160 |
Why?
|
| Child | 24 | 2015 | 79758 | 0.160 |
Why?
|
| Adolescent | 21 | 2017 | 87747 | 0.160 |
Why?
|
| Respiratory Tract Diseases | 1 | 2023 | 747 | 0.140 |
Why?
|
| Hospitalization | 2 | 2014 | 10761 | 0.140 |
Why?
|
| Parents | 6 | 2014 | 3547 | 0.140 |
Why?
|
| Telemedicine | 1 | 2013 | 3005 | 0.130 |
Why?
|
| Spatial Behavior | 1 | 2016 | 88 | 0.130 |
Why?
|
| Physician-Patient Relations | 1 | 2009 | 3242 | 0.130 |
Why?
|
| Students | 1 | 2005 | 1722 | 0.130 |
Why?
|
| Nephrogenic Fibrosing Dermopathy | 1 | 2015 | 42 | 0.130 |
Why?
|
| Enhancer Elements, Genetic | 3 | 2008 | 1356 | 0.120 |
Why?
|
| Emergency Service, Hospital | 2 | 2013 | 7809 | 0.120 |
Why?
|
| Severity of Illness Index | 7 | 2008 | 15827 | 0.110 |
Why?
|
| Leukemia, B-Cell | 1 | 2014 | 84 | 0.110 |
Why?
|
| Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 2014 | 121 | 0.110 |
Why?
|
| Leukemia, Experimental | 1 | 2014 | 225 | 0.110 |
Why?
|
| Health Expenditures | 2 | 2017 | 2359 | 0.110 |
Why?
|
| Renin-Angiotensin System | 2 | 2015 | 739 | 0.110 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2017 | 12281 | 0.110 |
Why?
|
| Infectious Bovine Rhinotracheitis | 1 | 2012 | 1 | 0.110 |
Why?
|
| Abortion, Veterinary | 1 | 2012 | 11 | 0.110 |
Why?
|
| Male | 34 | 2017 | 359413 | 0.100 |
Why?
|
| Space Perception | 1 | 2016 | 464 | 0.100 |
Why?
|
| Cotinine | 4 | 2014 | 203 | 0.100 |
Why?
|
| Administration, Inhalation | 2 | 2006 | 1156 | 0.100 |
Why?
|
| Medically Underserved Area | 1 | 2013 | 258 | 0.090 |
Why?
|
| Allergy and Immunology | 1 | 2012 | 175 | 0.090 |
Why?
|
| Environmental Exposure | 3 | 2014 | 4404 | 0.090 |
Why?
|
| Cost Savings | 1 | 2015 | 920 | 0.090 |
Why?
|
| Female | 33 | 2016 | 391011 | 0.090 |
Why?
|
| Allergens | 3 | 2007 | 1399 | 0.080 |
Why?
|
| Humans | 42 | 2017 | 760261 | 0.080 |
Why?
|
| Antibodies, Monoclonal | 1 | 2006 | 9196 | 0.080 |
Why?
|
| Practice Guidelines as Topic | 1 | 2006 | 7468 | 0.080 |
Why?
|
| Periodicity | 1 | 2010 | 349 | 0.080 |
Why?
|
| Acetates | 1 | 2010 | 322 | 0.080 |
Why?
|
| Delivery of Health Care | 2 | 2008 | 5324 | 0.080 |
Why?
|
| Behavior Therapy | 1 | 2014 | 869 | 0.080 |
Why?
|
| Advisory Committees | 1 | 2012 | 789 | 0.080 |
Why?
|
| Hospital Costs | 1 | 2014 | 976 | 0.080 |
Why?
|
| Mass Screening | 1 | 2004 | 5422 | 0.080 |
Why?
|
| Meconium Aspiration Syndrome | 1 | 2007 | 30 | 0.070 |
Why?
|
| Bone Marrow Cells | 2 | 2014 | 2424 | 0.070 |
Why?
|
| Program Evaluation | 2 | 2006 | 2494 | 0.070 |
Why?
|
| Motor Activity | 2 | 2010 | 2687 | 0.070 |
Why?
|
| Lateral Ventricles | 2 | 2005 | 146 | 0.070 |
Why?
|
| School Nursing | 1 | 2006 | 33 | 0.070 |
Why?
|
| Socioeconomic Factors | 5 | 2008 | 7803 | 0.070 |
Why?
|
| Cross-Sectional Studies | 3 | 2017 | 25928 | 0.070 |
Why?
|
| Young Adult | 5 | 2017 | 58673 | 0.070 |
Why?
|
| Sp1 Transcription Factor | 2 | 2004 | 140 | 0.070 |
Why?
|
| Internet | 2 | 2009 | 3074 | 0.060 |
Why?
|
| California | 2 | 2007 | 1416 | 0.060 |
Why?
|
| Attention | 1 | 2016 | 2386 | 0.060 |
Why?
|
| Lymphocyte Count | 1 | 2007 | 780 | 0.060 |
Why?
|
| Family Characteristics | 3 | 2007 | 1001 | 0.060 |
Why?
|
| Pharmaceutical Services | 1 | 2006 | 141 | 0.060 |
Why?
|
| Cattle | 3 | 2023 | 3847 | 0.060 |
Why?
|
| Sex Factors | 2 | 2017 | 10530 | 0.060 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 2 | 2004 | 286 | 0.060 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2006 | 357 | 0.060 |
Why?
|
| Health Care Reform | 1 | 2014 | 1245 | 0.060 |
Why?
|
| Education, Continuing | 1 | 2005 | 114 | 0.060 |
Why?
|
| Quinolines | 1 | 2010 | 759 | 0.060 |
Why?
|
| Dust | 1 | 2007 | 483 | 0.060 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2008 | 789 | 0.060 |
Why?
|
| Case Management | 1 | 2006 | 273 | 0.060 |
Why?
|
| Clinical Protocols | 1 | 2010 | 1439 | 0.060 |
Why?
|
| Tetraodontiformes | 1 | 2004 | 12 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 3 | 2012 | 6067 | 0.060 |
Why?
|
| Pharmacists | 1 | 2006 | 259 | 0.060 |
Why?
|
| Pest Control, Biological | 1 | 2003 | 20 | 0.060 |
Why?
|
| Obesity | 1 | 2006 | 12915 | 0.060 |
Why?
|
| Professional Role | 1 | 2006 | 311 | 0.060 |
Why?
|
| Disease Models, Animal | 4 | 2015 | 18134 | 0.060 |
Why?
|
| Neural Inhibition | 1 | 2007 | 589 | 0.060 |
Why?
|
| Adult | 11 | 2017 | 219847 | 0.060 |
Why?
|
| Mice, Inbred C3H | 4 | 2007 | 915 | 0.060 |
Why?
|
| Cockroaches | 1 | 2003 | 97 | 0.060 |
Why?
|
| Pyroglyphidae | 1 | 2003 | 89 | 0.050 |
Why?
|
| Spectral Karyotyping | 1 | 2002 | 12 | 0.050 |
Why?
|
| Environmental Monitoring | 3 | 2007 | 1441 | 0.050 |
Why?
|
| Kidney | 3 | 2015 | 7072 | 0.050 |
Why?
|
| Health Services | 1 | 2008 | 754 | 0.050 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2007 | 314 | 0.050 |
Why?
|
| Mobile Health Units | 1 | 2004 | 90 | 0.050 |
Why?
|
| Mice, Transgenic | 6 | 2015 | 9531 | 0.050 |
Why?
|
| Morbidity | 1 | 2008 | 1765 | 0.050 |
Why?
|
| Housing | 1 | 2007 | 664 | 0.050 |
Why?
|
| Comorbidity | 1 | 2017 | 10552 | 0.050 |
Why?
|
| Virus Shedding | 1 | 2003 | 111 | 0.050 |
Why?
|
| Schizophrenia | 3 | 2007 | 6915 | 0.050 |
Why?
|
| Knowledge | 1 | 2004 | 176 | 0.050 |
Why?
|
| Leukotriene Antagonists | 1 | 2003 | 124 | 0.050 |
Why?
|
| Mental Recall | 2 | 2005 | 1205 | 0.050 |
Why?
|
| Middle Aged | 8 | 2017 | 220175 | 0.050 |
Why?
|
| Logistic Models | 2 | 2008 | 13311 | 0.050 |
Why?
|
| Infant | 4 | 2015 | 36030 | 0.050 |
Why?
|
| Biological Specimen Banks | 1 | 2007 | 776 | 0.050 |
Why?
|
| Skin Tests | 1 | 2004 | 637 | 0.050 |
Why?
|
| Herpesviridae Infections | 1 | 2003 | 270 | 0.050 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2003 | 345 | 0.050 |
Why?
|
| Interleukin-10 | 1 | 2007 | 1174 | 0.050 |
Why?
|
| Patient Discharge | 1 | 2014 | 3475 | 0.050 |
Why?
|
| Cytokines | 2 | 2007 | 7345 | 0.050 |
Why?
|
| Age Factors | 1 | 2017 | 18415 | 0.050 |
Why?
|
| Retrospective Studies | 3 | 2017 | 80301 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 3 | 2012 | 5784 | 0.040 |
Why?
|
| Luminescent Proteins | 1 | 2002 | 835 | 0.040 |
Why?
|
| Gene Expression Profiling | 2 | 2007 | 9388 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2015 | 8018 | 0.040 |
Why?
|
| Body Mass Index | 1 | 2017 | 12901 | 0.040 |
Why?
|
| Poverty Areas | 3 | 2007 | 264 | 0.040 |
Why?
|
| Chromosomes | 1 | 2002 | 575 | 0.040 |
Why?
|
| Cost of Illness | 2 | 2006 | 1940 | 0.040 |
Why?
|
| Transgenes | 1 | 2002 | 1006 | 0.040 |
Why?
|
| Gene Expression Regulation | 4 | 2012 | 11902 | 0.040 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2004 | 1173 | 0.040 |
Why?
|
| Animals | 18 | 2023 | 167940 | 0.040 |
Why?
|
| United States | 7 | 2014 | 72363 | 0.040 |
Why?
|
| Family Health | 1 | 2003 | 1258 | 0.040 |
Why?
|
| Risk Factors | 3 | 2017 | 74269 | 0.040 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2006 | 1870 | 0.040 |
Why?
|
| Analysis of Variance | 1 | 2005 | 6242 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2009 | 9712 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2002 | 2500 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2010 | 12156 | 0.030 |
Why?
|
| Arkansas | 2 | 2006 | 59 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2009 | 3451 | 0.030 |
Why?
|
| Patient Participation | 1 | 2005 | 1437 | 0.030 |
Why?
|
| Guideline Adherence | 1 | 2006 | 2283 | 0.030 |
Why?
|
| Diarrhea | 1 | 2023 | 1341 | 0.030 |
Why?
|
| Transcription Factors | 3 | 2005 | 12100 | 0.030 |
Why?
|
| Population Surveillance | 1 | 2006 | 2609 | 0.030 |
Why?
|
| Transcription, Genetic | 2 | 2012 | 7593 | 0.030 |
Why?
|
| Receptors, Cell Surface | 1 | 2005 | 2825 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2005 | 2414 | 0.030 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2009 | 3159 | 0.030 |
Why?
|
| Pneumonia | 1 | 2007 | 2138 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2003 | 4044 | 0.030 |
Why?
|
| Aged | 5 | 2017 | 168995 | 0.030 |
Why?
|
| Models, Statistical | 1 | 2009 | 5073 | 0.030 |
Why?
|
| Patient Care Team | 1 | 2005 | 2510 | 0.030 |
Why?
|
| Adrenal Glands | 2 | 2008 | 556 | 0.030 |
Why?
|
| NFI Transcription Factors | 2 | 2004 | 42 | 0.030 |
Why?
|
| Electrophoretic Mobility Shift Assay | 2 | 2005 | 295 | 0.030 |
Why?
|
| Lung | 3 | 2007 | 9989 | 0.030 |
Why?
|
| Glucocorticoids | 1 | 2003 | 2143 | 0.030 |
Why?
|
| Drug Prescriptions | 1 | 2003 | 1673 | 0.030 |
Why?
|
| Breeding | 1 | 2012 | 51 | 0.030 |
Why?
|
| Poverty | 3 | 2014 | 2695 | 0.030 |
Why?
|
| Utilization Review | 1 | 2014 | 383 | 0.030 |
Why?
|
| Mice | 10 | 2014 | 81216 | 0.030 |
Why?
|
| Treatment Outcome | 3 | 2010 | 64947 | 0.030 |
Why?
|
| Zebrafish | 1 | 2004 | 2996 | 0.030 |
Why?
|
| Clozapine | 2 | 2007 | 506 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2004 | 14656 | 0.020 |
Why?
|
| Transfection | 3 | 2005 | 5782 | 0.020 |
Why?
|
| Antibodies, Viral | 1 | 2023 | 3145 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2007 | 8498 | 0.020 |
Why?
|
| Binding Sites | 3 | 2005 | 6050 | 0.020 |
Why?
|
| Kidney Neoplasms | 1 | 2007 | 4312 | 0.020 |
Why?
|
| Vaccination | 1 | 2023 | 3360 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 5 | 2008 | 22025 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 2 | 2008 | 2056 | 0.020 |
Why?
|
| Sulfides | 1 | 2010 | 171 | 0.020 |
Why?
|
| Pregnancy Rate | 1 | 2012 | 650 | 0.020 |
Why?
|
| Smoking | 2 | 2003 | 9070 | 0.020 |
Why?
|
| Anti-Allergic Agents | 1 | 2010 | 148 | 0.020 |
Why?
|
| DNA-Binding Proteins | 2 | 2004 | 9590 | 0.020 |
Why?
|
| Cyclopropanes | 1 | 2010 | 431 | 0.020 |
Why?
|
| Submandibular Gland | 1 | 2008 | 87 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2007 | 4573 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2007 | 39254 | 0.020 |
Why?
|
| Genomics | 1 | 2004 | 5790 | 0.020 |
Why?
|
| Electroshock | 1 | 2007 | 121 | 0.020 |
Why?
|
| Electrophoresis, Capillary | 1 | 2007 | 63 | 0.020 |
Why?
|
| Spleen | 1 | 2014 | 2298 | 0.020 |
Why?
|
| Minority Health | 1 | 2008 | 80 | 0.020 |
Why?
|
| Medicaid | 2 | 2014 | 2811 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2008 | 3735 | 0.020 |
Why?
|
| Frozen Sections | 1 | 2007 | 153 | 0.020 |
Why?
|
| Paraffin Embedding | 1 | 2007 | 302 | 0.020 |
Why?
|
| Tissue Fixation | 1 | 2007 | 241 | 0.020 |
Why?
|
| Behavior, Animal | 2 | 2005 | 1861 | 0.020 |
Why?
|
| Haloperidol | 1 | 2007 | 389 | 0.020 |
Why?
|
| Mutation | 3 | 2008 | 29950 | 0.020 |
Why?
|
| Genes, Neoplasm | 1 | 2007 | 370 | 0.020 |
Why?
|
| RNA, Messenger | 3 | 2007 | 12762 | 0.020 |
Why?
|
| Risperidone | 1 | 2007 | 379 | 0.020 |
Why?
|
| Prevalence | 3 | 2007 | 15687 | 0.020 |
Why?
|
| Mice, Neurologic Mutants | 1 | 2005 | 107 | 0.020 |
Why?
|
| Proto-Oncogene Protein c-ets-1 | 1 | 2005 | 63 | 0.020 |
Why?
|
| Fetus | 1 | 2012 | 1859 | 0.020 |
Why?
|
| Suburban Population | 1 | 2004 | 54 | 0.020 |
Why?
|
| DNA Mutational Analysis | 2 | 2004 | 4109 | 0.020 |
Why?
|
| RNA, Neoplasm | 1 | 2007 | 749 | 0.020 |
Why?
|
| Oncostatin M | 1 | 2004 | 42 | 0.010 |
Why?
|
| Sp3 Transcription Factor | 1 | 2004 | 28 | 0.010 |
Why?
|
| Hematopoiesis | 1 | 2014 | 2063 | 0.010 |
Why?
|
| Seasons | 1 | 2010 | 1523 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2008 | 2473 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2005 | 311 | 0.010 |
Why?
|
| Diarrhea Virus 2, Bovine Viral | 1 | 2003 | 1 | 0.010 |
Why?
|
| Interleukin-8 | 1 | 2007 | 698 | 0.010 |
Why?
|
| Dizocilpine Maleate | 1 | 2004 | 172 | 0.010 |
Why?
|
| Vietnam | 1 | 2004 | 411 | 0.010 |
Why?
|
| Transcription Initiation Site | 1 | 2004 | 186 | 0.010 |
Why?
|
| Bone Marrow | 1 | 2014 | 2918 | 0.010 |
Why?
|
| Time Factors | 3 | 2014 | 40133 | 0.010 |
Why?
|
| Transferases | 1 | 2003 | 72 | 0.010 |
Why?
|
| Acoustic Stimulation | 1 | 2007 | 1232 | 0.010 |
Why?
|
| Y-Box-Binding Protein 1 | 1 | 2003 | 41 | 0.010 |
Why?
|
| COS Cells | 1 | 2005 | 1129 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2005 | 17766 | 0.010 |
Why?
|
| Cats | 1 | 2004 | 976 | 0.010 |
Why?
|
| Respiratory Function Tests | 1 | 2007 | 1684 | 0.010 |
Why?
|
| Reproducibility of Results | 3 | 2007 | 20048 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 2002 | 778 | 0.010 |
Why?
|
| Receptor, Notch1 | 1 | 2005 | 495 | 0.010 |
Why?
|
| Insurance, Health | 1 | 2014 | 2500 | 0.010 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2004 | 616 | 0.010 |
Why?
|
| Trachea | 1 | 2007 | 1082 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 2002 | 751 | 0.010 |
Why?
|
| Schools | 1 | 2010 | 1474 | 0.010 |
Why?
|
| Fungi | 1 | 2004 | 338 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2008 | 2651 | 0.010 |
Why?
|
| Serologic Tests | 1 | 2003 | 383 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2005 | 1234 | 0.010 |
Why?
|
| Respiration | 1 | 2007 | 1648 | 0.010 |
Why?
|
| Disease Progression | 2 | 2010 | 13505 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 2004 | 1250 | 0.010 |
Why?
|
| Molecular Sequence Data | 2 | 2004 | 17628 | 0.010 |
Why?
|
| Cultural Diversity | 1 | 2004 | 361 | 0.010 |
Why?
|
| Sentinel Surveillance | 1 | 2002 | 293 | 0.010 |
Why?
|
| Length of Stay | 1 | 2014 | 6472 | 0.010 |
Why?
|
| Epigenesis, Genetic | 1 | 2014 | 3758 | 0.010 |
Why?
|
| Homozygote | 1 | 2005 | 1786 | 0.010 |
Why?
|
| Corpus Callosum | 1 | 2005 | 749 | 0.010 |
Why?
|
| Child Welfare | 1 | 2003 | 517 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2004 | 2178 | 0.010 |
Why?
|
| Probability | 1 | 2004 | 2476 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 2007 | 2214 | 0.010 |
Why?
|
| Nicotine | 1 | 2004 | 677 | 0.010 |
Why?
|
| Dogs | 1 | 2004 | 3843 | 0.010 |
Why?
|
| Plasmids | 1 | 2004 | 2277 | 0.010 |
Why?
|
| Self Care | 1 | 2004 | 793 | 0.010 |
Why?
|
| Mammals | 1 | 2004 | 1129 | 0.010 |
Why?
|
| Gene Dosage | 1 | 2002 | 1218 | 0.010 |
Why?
|
| Heterozygote | 1 | 2005 | 2797 | 0.010 |
Why?
|
| Gestational Age | 1 | 2007 | 3564 | 0.010 |
Why?
|
| Benzodiazepines | 1 | 2004 | 1132 | 0.010 |
Why?
|
| Arteries | 1 | 2002 | 1126 | 0.010 |
Why?
|
| Infant, Premature | 1 | 2007 | 2091 | 0.010 |
Why?
|
| Infant, Newborn | 2 | 2007 | 26168 | 0.010 |
Why?
|
| Pregnancy | 2 | 2012 | 29725 | 0.010 |
Why?
|
| Phylogeny | 1 | 2004 | 2775 | 0.010 |
Why?
|
| Air Pollution, Indoor | 1 | 2003 | 891 | 0.010 |
Why?
|
| Inflammation | 2 | 2007 | 10757 | 0.010 |
Why?
|
| Signal Transduction | 2 | 2012 | 23363 | 0.010 |
Why?
|
| Genome | 1 | 2004 | 1739 | 0.010 |
Why?
|
| Evolution, Molecular | 1 | 2004 | 1884 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2003 | 6131 | 0.010 |
Why?
|
| Cell Division | 1 | 2002 | 4462 | 0.010 |
Why?
|
| Algorithms | 2 | 2006 | 13967 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2008 | 11064 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2007 | 10185 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2004 | 3207 | 0.010 |
Why?
|
| Antipsychotic Agents | 1 | 2007 | 3061 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 2005 | 2978 | 0.010 |
Why?
|
| Patient Education as Topic | 1 | 2004 | 2311 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2004 | 4357 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2002 | 6361 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2004 | 4717 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2005 | 4494 | 0.010 |
Why?
|
| Peptides | 1 | 2004 | 4358 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2004 | 13456 | 0.010 |
Why?
|
| Mothers | 1 | 2003 | 2186 | 0.010 |
Why?
|
| Computational Biology | 1 | 2004 | 3504 | 0.010 |
Why?
|
| Base Sequence | 1 | 2003 | 12447 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2003 | 3448 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2007 | 18968 | 0.010 |
Why?
|
| DNA | 1 | 2005 | 7236 | 0.010 |
Why?
|
| Smoking Cessation | 1 | 2003 | 2064 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2004 | 3530 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2007 | 54263 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 2008 | 5396 | 0.010 |
Why?
|
| Cell Line | 1 | 2004 | 15626 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2003 | 4409 | 0.010 |
Why?
|
| Brain Mapping | 1 | 2005 | 6562 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2004 | 3967 | 0.010 |
Why?
|
| Rats | 1 | 2005 | 23695 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 58947 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 2004 | 15273 | 0.000 |
Why?
|
| Nuclear Proteins | 1 | 2003 | 5793 | 0.000 |
Why?
|
| Prognosis | 1 | 2007 | 29636 | 0.000 |
Why?
|
| Longitudinal Studies | 1 | 2003 | 14482 | 0.000 |
Why?
|
| Cohort Studies | 1 | 2007 | 41317 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2005 | 36247 | 0.000 |
Why?
|